CNN: Opinion: Here’s why marijuana should not be reclassified as a lower-risk drug

Jun 27, 2024

This interview first appeared on CNN.com.

Recently it was announced that the current administration is considering the reclassification of marijuana.

Rigaku Analytical Devices' Global Director for Counter-Narcotics Technology, Michael W. Brown, was featured in a CNN.com article where he provides his opinion on how the reclassification could pose a major business opportunity for drug cartels.  He discusses how criminal networks could benefit, and what the impact could be on law enforcement.

 

Views expressed in this article are opinions of the authors, and do not necessarily reflect the views of Rigaku Analytical Devices.

Be sure to check out Michael's podcast 'The Opioid Matrix,' where he has a 360-degree discussion with all angles contributing to the current opioid crisis our communities face.

CoverArt_v2_2165

 

 

Michael W. Brown is the global director of counter-narcotics technology at Rigaku Analytical Devices. He has a distinguished career spanning more than 32 years as a Special Agent for the Drug Enforcement Administration (DEA). Most recently he was the DEA Headquarters staff coordinator for the Office of Foreign Operations for the Middle East-Europe-Afghanistan-India. Prior to that he served as the country attaché in India and Myanmar providing foreign advisory support for counter narcotic enforcement. He also spent 10 years in Pakistan as a special advisor to the US Embassy on various law enforcement issues. Michael is a graduate of the United States Ranger Training Battalion and has a master’s degree in Interdisciplinary Technology and Management from the University of Eastern Michigan.

Contact Us

Whether you're interested in getting a quote, want a demo, need technical support, or simply have a question, we're here to help.